NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC
Clinical trial NCT07318636 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07318636
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-20
- Primary completion
- 2026-12-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.